Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,894 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa.
Sader HS, Rhomberg PR, Huband MD, Critchley IA, Stone GG, Flamm RK, Jones RN. Sader HS, et al. J Clin Microbiol. 2018 May 25;56(6):e01960-17. doi: 10.1128/JCM.01960-17. Print 2018 Jun. J Clin Microbiol. 2018. PMID: 29563198 Free PMC article.
Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
Sader HS, Farrell DJ, Flamm RK, Jones RN. Sader HS, et al. Surg Infect (Larchmt). 2016 Aug;17(4):443-7. doi: 10.1089/sur.2015.209. Epub 2016 Mar 18. Surg Infect (Larchmt). 2016. PMID: 26990170 Clinical Trial.
Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).
Mendes RE, Farrell DJ, Sader HS, Flamm RK, Jones RN. Mendes RE, et al. J Antimicrob Chemother. 2015 Feb;70(2):498-504. doi: 10.1093/jac/dku421. Epub 2014 Oct 31. J Antimicrob Chemother. 2015. PMID: 25362568 Clinical Trial.
In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.
Pfaller MA, Messer SA, Rhomberg PR, Jones RN, Castanheira M. Pfaller MA, et al. J Clin Microbiol. 2013 Aug;51(8):2608-16. doi: 10.1128/JCM.00863-13. Epub 2013 Jun 5. J Clin Microbiol. 2013. PMID: 23740727 Free PMC article.
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M. Pfaller MA, et al. J Clin Microbiol. 2013 Aug;51(8):2571-81. doi: 10.1128/JCM.00308-13. Epub 2013 May 29. J Clin Microbiol. 2013. PMID: 23720791 Free PMC article.
Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011.
Jones RN, Glick T, Sader HS, Flamm RK, Ross JE, Rhomberg PR, Edson DC. Jones RN, et al. Diagn Microbiol Infect Dis. 2013 Apr;75(4):357-60. doi: 10.1016/j.diagmicrobio.2013.01.027. Epub 2013 Mar 6. Diagn Microbiol Infect Dis. 2013. PMID: 23481025
Worldwide appraisal and update (2010) of telavancin activity tested against a collection of Gram-positive clinical pathogens from five continents.
Mendes RE, Sader HS, Farrell DJ, Jones RN. Mendes RE, et al. Antimicrob Agents Chemother. 2012 Jul;56(7):3999-4004. doi: 10.1128/AAC.00011-12. Epub 2012 Apr 16. Antimicrob Agents Chemother. 2012. PMID: 22508304 Free PMC article.
1,894 results
Jump to page
Feedback